Gainers
-
Best Buy Co Inc (NYSE: BBY) rose 15.3 percent to
$37.82 in the pre-market trading session after the company reported stronger-than-expected results for its second quarter on
Tuesday.
-
Daktronics, Inc. (NASDAQ: DAKT) rose 15.4 percent
to $8.00 in pre-market trading following Q1 results. Daktronics reported quarterly earnings of $0.13 per share on revenue of
$157.1 million.
-
Amedica Corporation (NASDAQ: AMDA) rose 10.2
percent to $1.19 in the pre-market trading session as the company reported that its Intervertebral Fusion Device has received
510(k) premarket 'substantially equivalent' notification on Monday.
-
Shoe Carnival, Inc. (NASDAQ: SCVL) shares rose
5.7 percent to $29.09 in pre-market trading. Shoe Carnival will replace Sagent Pharmaceuticals Inc (NASDAQ: SGNT) in the S&P SmallCap 600 after the close of trading on
August 26.
-
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) rose 5.1
percent to $62.99 in pre-market trading. Eagle Pharmaceuticals will replace Cash America International Inc (NYSE:
CSH) in the S&P SmallCap 600 after the close of trading
on September 1.
-
NQ Mobile Inc (ADR) (NYSE: NQ) shares rose 5.1
percent to $4.74 in pre-market trading following Q2 results. NQ Mobile reported Q2 non-GAAP net income of $7.6 million or $0.08
per ADS, compared to $7.0 million in last year's comparable quarter. The company reported an 18 percent increase in sales to
$83.7 million.
-
Tableau Software Inc (NYSE: DATA) shares rose 4.8
percent to $57.50 in pre-market trading after appointing Amazon.com, Inc.'s (NASDAQ: AMZN) former executive Adam Selipsky as its new CEO.
-
Chemical Financial Corporation (NASDAQ: CHFC)
rose 4.3 percent to $47.40 in pre-market trading. Chemical Financial will replace SUPERVALU INC. (NYSE: SVU) in the S&P MidCap 400 after the close of trading on August
31.
-
Monsanto Company (NYSE: MON) rose 4.1 percent to
$108.75 in pre-market trading as Bloomberg reported progress in talks with Bayer.
-
CF Industries Holdings, Inc. (NYSE: CF) shares rose
3.2 percent to $24.45 in pre-market trading. UBS upgraded CF Industries from Neutral to Buy and raised the price target from
$22.00 to $28.00.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Xtera Communications Inc (NASDAQ: XCOM) shares
fell 48 percent to $0.364 in the pre-market trading session after the company reported that it has received a notice of
termination of the Master Manufacturing Agreement with Foxconn.
-
Sophiris Bio Inc (NASDAQ: SPHS) shares fell 28
percent to $4.19 in pre-market trading on the announcement of an equity offering of stock and warrants.
-
Tokai Pharmaceuticals Inc (NASDAQ: TKAI) shares
fell 17.7 percent to $1.12 in pre-market trading as the company announced plans to discontinue enrollment for Armor2 expansion
clinical trial.
-
Sinovac Biotech Ltd. (NASDAQ: SVA) shares fell
16.5 percent to $5.00 in pre-market trading following Q2 results. Sinovac posted a quarterly loss of $0.17 per share on revenue
of $1.38 billion.
-
Zoe's Kitchen Inc (NYSE: ZOES) shares fell 13.2
percent to $32.35 in pre-market trading. Zoe's Kitchen reported in-line earnings for the second quarter, but revenue missed
analysts’ estimates. The company also trimmed its 2016 revenue outlook.
-
SeaChange International (NYSE: SEAC) shares fell
9.6 percent to $3.00 in pre-market trading after the company issued a weak forecast for the second quarter.
-
Premier Inc (NASDAQ: PINC) shares fell 8.5
percent to $30.89 in pre-market trading after the company posted downbeat quarterly results.
-
Cosi Inc (NASDAQ: COSI) fell 6.8 percent to
$0.290 in pre-market trading after the announcement that CEO and President Robert Dourney had been fired, while CFO Miguel
Rossy-Donovan had resigned, to work for another company. Board member Patrick Bennett will serve as interim CEO until a
permanent replacement is found.
-
J M Smucker Co (NYSE: SJM) shares fell 4.2 percent
to $149.60 in pre-market trading. Smucker reported better-than-expected first-quarter earnings, but revenue fell short of
estimates. The company maintained its adjusted EPS forecast for the full year.
-
Tuniu Corp (NASDAQ: TOUR) fell 4.1 percent to
$9.12 in pre-market trading. Tuniu reported a Q2 loss of $0.90 per ADS on revenue of $355.45 million and announced a $150
million share repurchase program.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.